TSE:6197Healthcare
Solasto (TSE:6197) Margin Compression And Q4 EPS Slump Test Earnings Quality Narratives
Solasto (TSE:6197) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥35.5 billion and basic EPS of ¥1.88, while trailing twelve month revenue stands at ¥141.1 billion and EPS at ¥40.81, setting the scene for a results season that focuses squarely on earnings quality. Over recent periods the company has seen quarterly revenue move from ¥34.5 billion in FY 2025 Q4 to around ¥35.5 billion in FY 2026 Q4. Over the same period, EPS shifted from ¥7.23 to ¥1.88, leaving investors...